Zafgen Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Zafgen Inc announces pricing of initial public offering
Zafgen Inc:Says pricing of its initial public offering of 6,000,000 shares of its common stock at a price to the public of $16.00 per share, before underwriting discounts.All of the common stock is being offered by Zafgen.In addition, Zafgen has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any.shares are expected to begin trading on the NASDAQ Global Market on June 19, 2014 under the symbol ZFGN.Leerink Partners LLC and Cowen and Company, LLC are acting as joint book-running managers of the offering.Canaccord Genuity Inc. and JMP Securities LLC are acting as co-managers.
Latest Key Developments in Biotechnology
- Pfenex Inc announces pricing of initial public offering
- Gene Techno Science Co Ltd to receive research subsidy from Northern Advancement Center for Science & Technology
- Incyte Corp announces top-line results from RELIEF trial of Ruxolitinib in patients with Polycythemia Vera
- Sangamo Biosciences Inc reaffirms FY 2014 revenue guidance
- Share this
- Digg this